In Law360, Tom Bulleit Examines Trump’s Latest Drug Pricing Executive Order

In The News
September 15, 2020
Thomas N. Bulleit
Capital Insights.

In an article published by Law360, health care partner Tom Bulleit (Washington, D.C.) discussed President Trump’s latest drug pricing executive order that seeks to sharply cut drug prices by capping prices of Medicare Part B and Part D drugs.

Tom explained that the executive order, which came right before the U.S. presidential election, would be met with legal challenges that would set up further obstacles to implementation.


Thomas N. Bulleit
Thomas N. Bulleit
Retired Partner